Balanced news tone
News Sentiment
AZN sentiment intelligence
AstraZeneca PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
31 relevant articles
Price is moving more forcefully than the current news tone suggests.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-4.6% over one week, -0.6% over four weeks, trend inactive, and materially above fair value.
AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
90/100 classification
One-week reaction
-4.6%
Price reacting lower
Trend fit
Trend inactive
-0.6% over four weeks
Fair value
78.8%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
18
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Jun 2026 02:07
- Source
- Market source
simplywall.st
Direct company coverage
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 16:33
- Source
- simplywall.st
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 13:09
- Source
- Market source
Market source
Direct company coverage
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 22:15
- Source
- Market source
Stock Titan
Direct company coverage
AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 20:05
- Source
- Stock Titan
Zacks Investment Research
Direct company coverage
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 13:58
- Source
- Zacks Investment Research
The Economic Times
Direct company coverage
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 11 Jun 2026 07:00
- Source
- The Economic Times
Market source
Direct company coverage
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi‑Year Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
Selling pressure pushes AstraZeneca stock lower in today's trading
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
Why is AstraZeneca stock down today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Traders Union
TradingKey
Direct company coverage
AstraZeneca PLC Stock (AZN) Closed Down by 3.17% on Jun 1: Facts Behind the Movement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- TradingKey
GuruFocus
Direct company coverage
AstraZeneca PLC (AZN) Stock Down 3.2% but Still Overvalued -- GF Score: 84/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- GuruFocus
Traders Union
Direct company coverage
Flat trading for AstraZeneca stock as GBX13,902 resistance keeps gains in check
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Traders Union
Market source
Direct company coverage
A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
AstraZeneca stock price forecast: GBX13,000 support holds as AZN edges lower
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 08 May 2026 07:00
- Source
- Traders Union
Market source
Direct company coverage
Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Reuters
Direct company coverage
AstraZeneca shares drop after US regulators vote against breast cancer drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Reuters
CNBC
Direct company coverage
AstraZeneca stock falls after FDA panel votes against new cancer drug
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- CNBC
Market source
Direct company coverage
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
AstraZeneca stock slips as weak momentum limits further upside
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
AstraZeneca stock holds steady after Assetmark Inc. and Pursuit Wealth buy shares
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Traders Union
The Economic Times
Direct company coverage
AstraZeneca Pharma India - Over 30 MF schemes trimmed holdings in 8 stocks in March ’26. Do you own any?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- The Economic Times
Traders Union
Direct company coverage
AstraZeneca stock holds steady after $191 million grant for Albemarle facility approved
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Traders Union
Market source
Direct company coverage
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
Strong clinical milestones drive AstraZeneca stock higher despite mixed momentum readings
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- Traders Union
AstraZeneca
Direct company coverage
AstraZeneca begins trading on the New York Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- AstraZeneca
Pharmaceutical Technology
Direct company coverage
AstraZeneca’s shares rise as it addresses China investigation
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 06 Feb 2025 08:00
- Source
- Pharmaceutical Technology
Reuters
Direct company coverage
Argentina pushes AstraZeneca on COVID-19 vaccine supply amid holdups
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 28 Apr 2021 07:00
- Source
- Reuters